摘要
目的:建立测定小鼠血液及各组织样品中紫杉醇含量测定的HPLC方法,考察比较包载紫杉醇(paclitaxel,PTX)的聚乙二醇-聚乳酸-聚-β-氨基酯(PELA-PBAE)与聚乙二醇-聚乳酸(PELA)纳米胶束在正常小鼠体内各组织的分布情况及药动学参数。方法:采用尾静脉注射法给予小鼠紫杉醇注射液(PTX injection)、PELA/PTX纳米胶束和PELA-PBAE/PTX纳米胶束,给药量为5 mg·kg^(-1)(以紫杉醇计),比较其药动学参数。结果:与紫杉醇注射液相比,2种纳米胶束在小鼠体内的AUC增大,平均滞留时间延长,在血、肺中蓄积量增多,在心脏蓄积减少;与非p H敏感性紫杉醇纳米胶束PELA/PTX相比,PELA-PBAE/PTX各药动学参数没有显著变化。结论:聚-β-氨基酯的引入没有改变原有胶束的优异性能,同样可以降低网状内皮系统对胶束的吞噬,可提高紫杉醇的生物利用度、延长药物的作用时间并降低紫杉醇的潜在心脏毒性。
Objective: To establish an HPLC method for determining the content of paclitaxel in mouse plasma and other tissues,and investigate the pharmacokinetics and tissue distribution of paclitaxel( PTX) in drugloaded PELA-PBAE( PELA-PBAE / PTX) and PELA( PELA / PTX) micelles in comparison with the commercially available PTX injection. Methods: The healthy female Balb / c mice were intravenously injected with PTX injection,PELA / PTX and PELA-PBAE / PTX via the tail vein,respectively. An HPLC method was established to determine the concentration of PTX in plasma and tissue samples. Results: Compared with the commercial PTX injection,the main pharmacokinetic parameters such as the AUC and MRT of both PELA / PTX and PELA-PBAE / PTX were significantly increased. After injection,PTX in the drug-loaded nano-micelles was mainly distributed in plasma and lung,whereas the PTX injection was primarily in liver and spleen. Conclusion: The p H-responsive PELAPBAEmicelles,as well as PELA micelles,could help the drug to escape from the capture of reticuloendothelial system( RES),increase the bioavailability,prolong the circulation time in plasma,and minimize the potential cardio-toxicity of PTX.
出处
《中国新药杂志》
CAS
CSCD
北大核心
2016年第8期933-937,共5页
Chinese Journal of New Drugs
基金
国家"重大新药创制"科技重大专项(2014ZX09304307001)
北京市自然科学基金(2152036)